Organization Overview
Alternative names
afatinib (gilotrif) (7 trials)
alemtuzumab (campath) (2 trials)
autologous hematopoietic cell (1 trial)
bendamustine (treanda) (7 trials)
bevacizumab (avastin) (3 trials)
bicalutamide (casodex) (1 trial)
brigatinib (alunbrig) (1 trial)
capecitabine (xeloda) (5 trials)
carboplatin (paraplatin) (8 trials)
cyanocobalamin (berocca) (1 trial)
cyclophosphamide (cytoxan) (2 trials)
cytarabine (cytosar-u) (1 trial)
dabrafenib (tafinlar) (4 trials)
decitabine (dacogen) (2 trials)
diphenhydramine (benadryl) (1 trial)
docetaxel (taxotere) (4 trials)
doxorubicin (Doxil) (4 trials)
enzalutamide (xtandi) (6 trials)
filgrastim (neupogen) (1 trial)
gemcitabine (gemzar) (3 trials)
irinotecan (Camptosar) (4 trials)
methylprednisolone (medrol) (1 trial)
mirvetuximab soravtansine (2 trials)
ofatumumab (arzerra) (4 trials)
osimertinib (tagrisso) (2 trials)
Adenocarcinoma (Phase 2)
Adenocarcinoma, Follicular (Phase 2)
Astrocytoma (Phase 2)
Biliary Tract Neoplasms (Phase 1)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoid Tumor (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Endometrioid (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 1)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Verrucous (Phase 2)
Cholangiocarcinoma (Phase 1)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Disease Progression (Phase 2)
Endometrial Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Histiocytoma (Phase 2)
Histiocytoma, Malignant Fibrous (Phase 2)
Hypersensitivity (Phase 2)
Laryngeal Diseases (Phase 2)
Laryngeal Neoplasms (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Liver Neoplasms (Phase 1)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 1)
Melanoma (Phase 2)
Mouth Neoplasms (Phase 2)
Multiple Myeloma (Phase 1)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 1)
Neoplasms, Squamous Cell (Phase 2)
Neoplasms, Unknown Primary (Phase 2)
Neoplastic Cells, Circulating (Phase 2)
Nerve Sheath Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 2)
Neurofibrosarcoma (Phase 2)
Oligodendroglioma (Phase 2)
Oropharyngeal Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Paranasal Sinus Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Pneumonia (Phase 2)
Prostatic Neoplasms (Phase 2)
Radiation Pneumonitis (Phase 2)
Rectal Neoplasms (Phase 2)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Thyroid Cancer, Papillary (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Tongue Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Uveal Neoplasms (Phase 2)